NNC 55-0414

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC 55-0414, covering 2017-02-24 to 2017-02-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes [Phase 1]